A.R.T. Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-195,480
Closed -$383K 1090
2019
Q4
$383K Buy
195,480
+153,541
+366% +$577K 0.02% 945
2019
Q3
$215K Sell
41,939
-42,500
-50% -$257K 0.01% 1167
2019
Q2
$605K Buy
84,439
+28,923
+52% +$328K 0.03% 673
2019
Q1
$737K Buy
55,516
+43,300
+354% +$461K 0.04% 590
2018
Q4
$96K Sell
12,216
-43,599
-78% -$415K 0.01% 1170
2018
Q3
$618K Buy
+55,815
New +$693K 0.03% 762
2018
Q2
Sell
-57,631
Closed -$748K 1829
2018
Q1
$748K Buy
57,631
+42,400
+278% +$527K 0.03% 777
2017
Q4
$140K Buy
+15,231
New +$130K 0.01% 1220
2015
Q3
Sell
-36,069
Closed -$97K 1660
2015
Q2
$97K Buy
36,069
+20,940
+138% +$86K ﹤0.01% 1370
2015
Q1
$104K Buy
+15,129
New +$145K ﹤0.01% 1315

Other funds holding CBAY